Effects of increasing carbon nanofiber density in polyurethane composites for inhibiting bladder cancer cell functions

Tissue Engineering - Part A

Volumn 17, Issue 13-14, 2011, Pages 1879-1889

  Tsang, Melissa ^a   Chun, Young Wook ^a   Im, Yeon Min ^b   Khang, Dongwoo ^b   Webster, Thomas J ^a  

^a Brown University   (United States)

^b Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; ATOMIC FORCE MICROSCOPY; ATOMIC SPECTROSCOPY; CARBON NANOFIBERS; CELL PROLIFERATION; CYTOLOGY; DISEASES; GLYCOPROTEINS; INFRARED SPECTROSCOPY; MACROPHAGES; MECHANICAL PROPERTIES; MEDICAL APPLICATIONS; NANOCOMPOSITES; NANOTECHNOLOGY; PHOTOELECTRON SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTIES; SURFACE ROUGHNESS; TUMORS; X RAY PHOTOELECTRON SPECTROSCOPY;

BIOMEDICAL APPLICATIONS; BLADDER CANCER CELLS; BLADDER CANCERS; BLADDER TISSUE; CANCER CELLS; CANCEROUS CELLS; CELL PROLIFERATION RATE; CELLULAR RESPONSE; CHEMICAL COMPOSITIONS; NANO-SCALE SURFACE ROUGHNESS; NANOFIBER DENSITY; POLYURETHANE COMPOSITES; PRIMARY CELLS; TUMOR NECROSIS FACTOR ALPHA; UROTHELIAL CARCINOMA; UROTHELIAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VOLUME RATIO; WEIGHT RATIOS;

BIOMECHANICS;

CARBON; NANOCOMPOSITE; NANOFIBER; NUCLEAR MATRIX PROTEIN 22; NUCLEAR PROTEIN; POLYURETHAN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BLADDER TUMOR; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; SURFACE PROPERTY; TUMOR CELL LINE; ULTRASTRUCTURE;

CARBON; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; NANOCOMPOSITES; NANOFIBERS; NUCLEAR PROTEINS; POLYURETHANES; SURFACE PROPERTIES; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959546671     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0569     Document Type: Article

References (37)

1. Altekruse, S. F., Kosary, C. L., Krapcho, M., Neyman, N, Aminou, R., Waldron, W., Ruhl, J., Howlader, N, Tatalovich, Z., Cho, H., Mariotto, A., Eisner, M. P., Lewis, D. R., Cronin, K., Chen, H. S., Feuer, E. J., Stinchcomb, D. G., and Edwards, B. K. (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD. Available at http://seer.cancer.gov/ csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
2. Sharma, S., Ksheersagar, P., and Sharma, P. Diagnosis and treatment of bladder cancer. Am Fam Physician 80, 717, 2009.
3. Bevers, R. F., Battermann, J. J., Gietema, J. A., Hulsbergen-Van de Kaa, C. A., de Reijke, T. M., Feller, N, and Witjes, J. A. Guideline on urothelial carcinoma of the bladder. Ned Tijdschr Geneeskd 153, A956, 2009.
4. Babjuk, M., Oosterlinck, W., Sylvester, R., Kaasinen, E., Bohle, A., and Palou-Redorta, J. EAU guidelines on nonmuscle-invasive urothelial carcinoma of the bladder. Eur Urol 54, 303, 2008.
5. Malmstrom, P. U. Intravesical therapy of superficial bladder cancer. Crit Rev Oncol Hematol 47, 109, 2003.
6. Thapa, A., Miller, D. C., Webster, T. J., and Haberstroh, K. M. Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials 24, 2915, 2003.
7. Pattison, M. A., Wurster, S., Webster, T. J., and Haberstroh, K. M. Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials 26, 2491, 2005.
8. Chun, Y. W., Khang, D. W., Haberstroh, K. M., and Webster, T. J. The role of polymer nanosurface roughness and submicron pores in improving bladder urothelial cell density and inhibiting calcium oxalate stone formation. Nanotechnology 20, 085104, 2009.
9. Shin, H, Nichol, J. W., and Khademhosseini, A. Cell-adhesive and mechanically tunable glucose-based biodegradable hydrogels. Acta Biomater 7, 106, 2011.
10. ® surface with lotus leaf-like topography. Colloids Surf B Biointerfaces 77, 234, 2010.
11. Sen, R., Zhao, B., Perea, D., Itkis, M. E., Hu, H, Love, J., Bekyarova, E., and Haddon, R. C Preparation of singlewalled carbon nanotube reinforced polystyrene and polyurethane nanofibres and membranes by electrospinning. Nano Lett 4, 459, 2004.
12. Kuan, H. C, Chen-Chi, M. M., Chang, W. P., Yuen, S. M., Wu, H. H., and Lee, T. M. Synthesis, thermal, mechanical and rheological properties of multiwall carbon nanotube/waterborne polyurethane nanocomposites. Composites Sci Technol 65, 1703, 2005.
13. Sahoo, N. G., Rana, S., Cho, J. W., Li, L., and Chan, S. H. Polymer nanocomposites based on functionalized carbon nanotubes. Prog Polym Sci 35, 837, 2010.
14. Tran, P. A., Zhang, L., and Webster, T. J. Carbon nanofibers and carbon nanotubes in regenerative medicine. Adv Drug Deliv Rev 61, 1097, 2009.
15. Chun, Y. W., Wang, W., Choi, J., Nam, T., Lee, Y., Cho, K., Im, Y., Kim, M., Gwon, Y., Kang, S. S., Lee, J. D., Lee, K., Khang, D., and Webster, T. J. Control of macrophage responses on hydrophobic and hydrophilic carbon nanostructures. Carbon 49, 2092, 2011.
16. Nielsen, M. E., Shariat, S. F., Karakiewicz, P. I., Lotan, Y., Rogers, C. G., Amiel, G. E., et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51, 699, 2007.
17. Kawakami, S., Arai, G., Hayashi, T., Fujii, Y., Xia, G., Kageyama, Y., and Kihara, K. PPARγ ligands suppress proliferation of human urothelial basal cells in vitro. J Cell Physiol 191, 310, 2002.
18. Hu, Z., Ai, Q., Xu, H., Ma, X., Li, H. Z., Shi, T. P., Wang, C., Gong, D. J., and Zhang, X. Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637. Urol Oncol 2009 [Epub ahead of print]; DOI: 10.1016/j.urolonc.2009.06.004.
19. Kim, E. J., Jeong, P., Quan, C., Kim, J., Bae, S. C., Yoon, S. J., et al. Genotypes of TNF-α, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for the clinical outcome of bladder cancer. Urology 65, 70, 2005.
20. Lokeshwar, V. B., and Soloway, M. S. Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 165, 1067, 2001.
21. Xia, G. S., Kumar, R., Hawes, D., Cai, J., Hassanieh, L., Groshen, S., et al. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol 175, 1245, 2006.
22. Farhat, W. A., Chen, J., Haig, J., Antoon, R., Litman, J., Sherman, C., Derwin, K., and Yeger, H. Porcine bladder acellular matrix (ACM): protein expression, mechanical properties. Biomed Mater 3, 025015, 2008.
23. Shin, K. Y., Moon, H. S., Park, H. Y., Lee, T. Y., Woo, Y. N., Kim, H. J., Lee, S. J., and Kong, G. Effects of tumor necrosis factor-α and interferon-γ on expressions of matrix metalloproteinase-2 and-9 in human bladder cancer cells. Cancer Lett 159, 127, 2000.
24. Lee, S. J., Park, S. S., Lee, U. S., Kim, W. J., and Moon, S. K. Signaling pathway for TNF-α-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anticancer molecule magnolol in human urinary bladder cancer 5637 cells. Int Immunopharmacol 8, 1821, 2008.
25. Förster, Y., Meye, A., Krause, S., and Schwenzer, B. Antisense-mediated VEGF suppression in bladder and breast cancer cells. Cancer Lett 212, 95, 2004.
26. Yang, C. C., Chu, K. C., and Yeh, W. M. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression. Urol Oncol 22, 1, 2004.
27. Price, R. L., Ellison, K., Haberstroh, K. M., and Webster, T. J. Nanometer surface roughness increases select osteoblast adhesion on carbon nanofiber compacts. J Biomed Mater Res A 70, 129, 2004.
28. Khang, D., Park, G. E., and Webster, T. J. Enhanced chondrocyte densities on carbon nanotube composites: the combined role of nanosurface roughness and electrical stimulation. J Biomed Mater Res 86, 253, 2008.
29. Parekh, A., and Weaver, M. A. Regulation of cancer invasiveness by the physical extracellular matrix environment. Cell Adhes Migr 3, 288, 2009.
30. Shariat, S. F., Casella, R., Wians, F. H., Jr., Ashfaq, R., Balko, J., Sulser, T., Gasser, T. C., and Sagalowsky, A. I. Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology. Eur Urol 45, 304, 2004.
31. Pelham, R. J., and Wang, Y. L. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci USA 94, 13661, 1997.
32. Sanchez-Carbayo, M., Socci, N. D., Charytonowicz, E., Lu, M., Prystowsky, M., Childs, G., and Cordon-Cardo, C. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. J Urol 174, 6973, 2002.
33. Colt, J. S., Karagas, M. R., and Schwenn, M. Occupation and bladder cancer in a population-based case-control study in northern New England. Occup Environ Med 68, 239, 2011.
34. Serra, C., Kogevinas, M., and Silverman, D. T. Work in the textile industry in Spain and bladder cancer. Occup Environ Med 65, 552, 2008.
35. Evans, C. P., Debruyne, F. M. J., Payne, H., Solsona, E., Teillac, P., and Tubaro, A. Bladder cancer: management and future directions. Eur Urol Suppl 6, 365, 2007.
36. Nepple, K. G., and O'Donnell, M. A. The optimal management of T1 high-grade bladder cancer. Can Urol Assoc J 3, S188, 2009.
37. Kulkarni, G. S., Hakenberg, O. W., Gschwend, J. E., Thalmann, G., Kassouf, W., Kamat, A., et al. An updated critical analysis of the treatment strategy for newly diagnosed highgrade T1 (Previously T1G3) bladder cancer. Eur Urol 57, 60, 2010.